Provia Laboratories™ Expands its Stem Cell Portfolio to Amniotic Fluid, Chorionic Villi, and Placenta
September 29, 2016Provia Laboratories, a leader in cGMP stem cell processing, banking and manufacturing, executed an agreement to license Biocell Group’s technology for processing stem cells from Amniotic Fluid, Chorionic Villi, and Placenta for the US and Asian markets.
